GSK3B and diabetic kidney disease: It is now well established from a variety of studies that GSK-3β in diabetic nephropathy mainly converge Wnt/β-catenin, PI3K/Akt/GSK-3β, epithelial–mesenchymal transition, etc (Cheng et al., 2016).